NeuroVision has collected $11.2m from backers including VSP Global and Johnson & Johnson for a round expected to close at $15m.
US-based retinal imaging system developer NeuroVision Imaging has raised $11.2m in series C funding from investors including eyewear and insurance provider VSP Global and medical product group Johnson & Johnson.
Family office Wildcat Capital Management led the round, which included Nikon-SBI Innovation Fund, a fund backed by optical and measurements equipment maker Nikon, as well as Whittier Ventures, part of investment management firm Whittier Trust.
Johnson & Johnson participated through corporate venturing unit Johnson & Johnson Innovation – JJDC. The…
